Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Long-Term Investments (2016 - 2024)

Historic Long-Term Investments for Marimed (MRMD) over the last 10 years, with Q1 2024 value amounting to $274000.0.

  • Marimed's Long-Term Investments changed N/A to $274000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $274000.0, marking a year-over-year change of. This contributed to the annual value of $221000.0 for FY2023, which is N/A changed from last year.
  • Per Marimed's latest filing, its Long-Term Investments stood at $274000.0 for Q1 2024.
  • Marimed's Long-Term Investments' 5-year high stood at $2.5 million during Q4 2020, with a 5-year trough of $89000.0 in Q2 2023.
  • Over the past 5 years, Marimed's median Long-Term Investments value was $1.4 million (recorded in 2022), while the average stood at $1.2 million.
  • In the last 5 years, Marimed's Long-Term Investments plummeted by 9489.85% in 2020 and then surged by 1873.74% in 2021.
  • Marimed's Long-Term Investments (Quarter) stood at $2.5 million in 2020, then tumbled by 90.05% to $251000.0 in 2021, then surged by 439.04% to $1.4 million in 2022, then crashed by 83.67% to $221000.0 in 2023, then grew by 23.98% to $274000.0 in 2024.
  • Its last three reported values are $274000.0 in Q1 2024, $221000.0 for Q4 2023, and $164000.0 during Q3 2023.